Changshan Biochemical Sets Price for ChiNext IPO
August 05, 2011 at 04:18 AM EDT
Hebei Changshan Biochemical Pharmaceutical hopes to raise 756 million RMB ($117.4 million) on the ChiNext Exchange. The underwriters will seek to place 27 million shares at a price of 28 RMB each. Changshan Biochemical is a heparin maker and derives 87% of its revenues from heparin APIs. More details.... Stock Symbol: (SHE: 300255) Share this with colleagues:
